Melphalan
Melphalan is a chemotherapeutic agent used in the treatment of a variety of cancers, including melanoma[1] and multiple myeloma.[2]
Melphalan Media
Mechanism of nucleotide alkylation by melphalan
Syntheses: U.S. Patent 3,032,584; U.S. Patent 3,032,585 (both 1962 to NRDC).
References
- ↑ Percutaneous hepatic perfusion with melphalan improved hepatic PFS in ocular, cutaneous melanoma | Hematology OncologyHemonctoday.com. Retrieved 2014-06-24.
- ↑ Cunningham, D.. High-dose melphalan for multiple myeloma: long-term follow-up data. Journal of Clinical Oncology 12 (4) (2014-06-20)Jco.ascopubs.org. p. 764–768. doi:10.1200/JCO.1994.12.4.764. Retrieved 2014-06-24.
